These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 17599769

  • 1. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Viganò MG, Villa E, Corti A.
    Cancer; 2007 Aug 15; 110(4):845-53. PubMed ID: 17599769
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.
    Tran TA, Kallakury BV, Ambros RA, Ross JS.
    Cancer; 1998 Jul 15; 83(2):276-82. PubMed ID: 9669810
    [Abstract] [Full Text] [Related]

  • 3. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.
    Cancer; 2001 Oct 01; 92(7):1896-904. PubMed ID: 11745263
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D, Soydinç HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E.
    Lung Cancer; 2008 Feb 01; 59(2):240-5. PubMed ID: 17875341
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.
    Schleusener JT, Tazelaar HD, Jung SH, Cha SS, Cera PJ, Myers JL, Creagan ET, Goldberg RM, Marschke RF.
    Cancer; 1996 Apr 01; 77(7):1284-91. PubMed ID: 8608504
    [Abstract] [Full Text] [Related]

  • 6. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun 01; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 7. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
    Goto N, Tsurumi H, Takemura M, Hara T, Sawada M, Kasahara S, Kanemura N, Yamada T, Shimizu M, Takahashi T, Tomita E, Seishima M, Takami T, Moriwaki H.
    Eur J Haematol; 2006 Sep 01; 77(3):217-25. PubMed ID: 16856931
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J, Kowalska M, Kotowicz B, Fuksiewicz M, Glogowski M, Wojcik E, Chechlinska M, Steffen J.
    Oncology; 2006 Sep 01; 70(2):115-25. PubMed ID: 16645324
    [Abstract] [Full Text] [Related]

  • 9. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E.
    Cancer Invest; 2006 Oct 01; 24(6):576-80. PubMed ID: 16982461
    [Abstract] [Full Text] [Related]

  • 10. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun 01; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma.
    Chang H, Iizasa T, Shibuya K, Iyoda A, Suzuki M, Moriya Y, Liu TL, Hiwasa T, Hiroshima K, Fujisawa T.
    Cancer; 2004 Apr 15; 100(8):1665-72. PubMed ID: 15073855
    [Abstract] [Full Text] [Related]

  • 12. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH, Zell JA, Ziogas A, Anton-Culver H.
    Cancer; 2008 May 01; 112(9):2011-20. PubMed ID: 18361399
    [Abstract] [Full Text] [Related]

  • 13. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2003 May 01; 23(5b):4085-93. PubMed ID: 14666606
    [Abstract] [Full Text] [Related]

  • 14. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
    Szaflarska A, Szczepanik A, Siedlar M, Czupryna A, Sierzega M, Popiela T, Zembala M.
    Anticancer Res; 2009 Dec 01; 29(12):5005-12. PubMed ID: 20044609
    [Abstract] [Full Text] [Related]

  • 15. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.
    Cancer; 2007 Jul 01; 110(1):215-23. PubMed ID: 17508409
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A, Terzi A, De Manzoni G, Bresaola E, Viale G.
    Cancer; 2003 May 15; 97(10):2487-97. PubMed ID: 12733148
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
    Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Minamiya Y, Ogawa J.
    Clin Cancer Res; 2005 Jul 15; 11(14):5084-9. PubMed ID: 16033821
    [Abstract] [Full Text] [Related]

  • 18. Neuroendocrine differentiation in stage D2 prostate cancers.
    Kamiya N, Suzuki H, Kawamura K, Imamoto T, Naya Y, Tochigi N, Kakuta Y, Yamaguchi K, Ishikura H, Ichikawa T.
    Int J Urol; 2008 May 15; 15(5):423-8. PubMed ID: 18452460
    [Abstract] [Full Text] [Related]

  • 19. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma.
    Su TR, Chang KL, Lee CH, Chen CH, Yang YH, Shieh TY.
    Oral Oncol; 2004 Sep 15; 40(8):804-10. PubMed ID: 15288835
    [Abstract] [Full Text] [Related]

  • 20. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
    Berruti A, Mosca A, Tucci M, Terrone C, Torta M, Tarabuzzi R, Russo L, Cracco C, Bollito E, Scarpa RM, Angeli A, Dogliotti L.
    Endocr Relat Cancer; 2005 Mar 15; 12(1):109-17. PubMed ID: 15788643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.